US Archives - Page 102 of 119 - European Medical Journal

Melioidosis in Patients with Cancer, A Cloaked Menace

Melioidosis is an infection encountered in tropical climates, endemic to South Asia and Northern Australia. Burkholderia pseudomallei…

Rethinking Alzheimer's: Increasing Amyloid-β42 Slows Disease Progression

Researchers from the University of Cincinnati, Ohio, suggest that increasing levels of the brain protein amyloid-β 42 may slow cognitive decline in Alzheimer’s disease.

New Biologic for Atopic Dermatitis Receives FDA-Approval

Approval has been granted by the FDA for lebrikizumab-lbkz in treating moderate to severe atopic dermatitis in patients aged 12 and older.

Breakthrough in Immunotherapy Against ‘Pro-Tumor’ Immune Cells

Protective cells can be converted into tumor promoters after the immune system has been hijacked by cancer.

New Pathways Discovered in Viral Lung Fibrosis

Researchers have uncovered a critical mechanism behind why certain viral infections, such as COVID-19, lead to lasting lung damage.

Endothelin Blockade: A New Hope for Post-COVID Arthritis

Emerging research has linked COVID-19 to joint pain and osteoarthritis, but the precise mechanisms behind this connection and the damage to articular cartilage were previously unclear.

Is Radiotherapy Safe for Patients with Systemic Sclerosis?

The effects of radiotherapy on patients with systemic sclerosis (SSc) who develop cancer is a subject of growing concern due to the potential exacerbation of SSc symptoms and the risks of radiotherapy-related toxicity.

The Truth About Stiff-Person Syndrome

Stiff-person syndrome is a rare and disabling autoimmune disorder that presents evolving diagnostic challenges for clinicians.

Students Struggle with Dermatology Education Lacking in Diversity

Gaps in dermatology education have been spotlighted in preclinical medical students.

ChatGPT Triumph Over Physicians In Pediatric Pulmonology

LARGE language models are commended for offering support and ease of workload in healthcare settings. A recent study demonstrated that ChatGPT significantly outperformed trainee doctors in diagnosing complex respiratory conditions in children.